Some aspects of the drug therapy of type 2 diabetes mellitus in overweight patients
Journal Title: Міжнародний ендокринологічний журнал - Year 2019, Vol 15, Issue 5
Abstract
This is a mini-review of recent publications on hypoglycemic drugs applicable to the treatment of type 2 diabetes mellitus in overweight patients. The article discusses the following topics: the influence of medications on body weight, function of pancreatic beta-cells, indications for the intensive glycemic control and medication costs. Glucagon-like peptide-1 receptor agonists stimulate insulin secretion, slow down gastric emptying, cause satiety and reduce food intake, contributing to the weight loss. The sodium glucose cotransporter 2 inhibitors suppress the renal glucose reabsorption, lower blood pressure and contribute to a reduction of body weight. A body weight reduction should be awaited also from inhibitors of intestinal alpha-glucosidase. Hypoglycemic effects of the two latter drug classes are unrelated to the stimulation of insulin secretion by beta cells. It is known that the secretory function of pancreatic islets can be exhausted by a prolonged stimulation. In conclusion, the goals of glycemic control need to be individualized based on the age, prognosis, presence of cardiovascular disease, and risk of hypoglycemia. Appropriate management of hypertension, dyslipidemia, and other cardiovascular risk factors are of importance for the prevention of complications in type 2 diabetes mellitus.
Authors and Affiliations
S. V. Jargin
Keywords
Related Articles
- EP ID EP660877
- DOI 10.22141/2224-0721.15.5.2019.180046
- Views 67
- Downloads 0
The course of gastroduodenal bleedings in peptic ulcer patients with comorbid diabetes mellitus
Background. The prevalence of gastroduodenal ulcerative bleeding reaches 170 cases per 100,000 of the adult population, and the annual mortality due to them is 15 %. Comorbid diabetes mellitus (DM) is an independent risk...
Insulin Therapy in Clinical Practice
No abstract
Functional Foods in Complex Treatment of Patients with Metabolic Syndrome
Functional foods are intended for a systematic daily consumption and have a regulating effect on physiological functions, biochemical reactions and psychosocial behavior due to the normalization of microecological status...
Calcitonin, Osteocalcin and Osteopontin in Lung Cancer
Background. Lung cancer markers are low levels of the hormone calcitonin in the blood, and high levels of proteins osteocalcin and osteopontin, connected to each other, reflect the processes of bone metastasis and have a...
Dynamics of the vascular wall state in the treatment of patients with hypertension combined with obesity and diabetes mellitus
Background. Obesity and diabetes mellitus (DM) are considered to be the most important risk factors for arterial hypertension. Endothelial dysfunction is one of the principal causes of hypertension progression. Different...